See more
Should I buy or sell CynergisTek stock right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last twelve months. There are currently 1 hold rating f...
Are investors shorting CynergisTek?
CynergisTek saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 161,500 shares, an increase of...
When is CynergisTek's next earnings date?
CynergisTek is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for CynergisT...
How were CynergisTek's earnings last quarter?
CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its quarterly earnings results on Monday, May, 16th. The company reported ($0.07) earnings per share (...
Who are CynergisTek's key executives?
CynergisTek's management team includes the following people: Mr. Michael H. McMillan CISM , FHIMSS, Founder, CEO, Pres & Director (Age 65, Pay $...
Who are some of CynergisTek's key competitors?
Some companies that are related to CynergisTek include Research Solutions (RSSS) , Society Pass (SOPA) , Heritage Global (HGBL) , Net Savings L...
What other stocks do shareholders of CynergisTek own?
Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include SeaChange International...
What is CynergisTek's stock symbol?
CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."
Who are CynergisTek's major shareholders?
CynergisTek's stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC...
About CynergisTek
CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions
CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. It provides these services through assessment and technical testing, remediation, management, and validation services. The company was founded on September 7, 2017 and is headquartered in Austin, TX.
Where is CynergisTek located?
CynergisTek's stock was trading at $2.53 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CTEK stock has decreased by 48.2% and is now trading at $1.31. View which stocks have been most impacted by COVID-19.
What is a cynergistek?
and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.
Signals & Forecast
CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company offers assessment and audit, technical testing, remediation, management, and validation services. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.#N#More...
Support, Risk & Stop-loss
There are mixed signals in the stock today. The Cynergistek, Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Cynergistek, Inc. stock A Buy?
Cynergistek, Inc. finds support from accumulated volume at $1.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are very positive buying more shares than they are selling in Cynergistek, Inc
Cynergistek, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 2.71 million shares bought and 399.54 thousand shares sold. The last trade was done 84 days ago by Mcmillan Michael Henry who bough 10 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Premium Research for CTEK
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
CynergisTek, Inc. provides cyber security and information management consulting in healthcare industry. It specializes in privacy, security, compliance and document management.
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating virtually in the upcoming 42nd Annual Cowen Health Care Conference. Cytek’s management is scheduled to participate in a fireside chat on Wednesday, March 9th at 8:10 a.m.
Reilly Financial Advisors, Llc Buys Sony Group Corp, The Toronto-Dominion Bank, Carrier Global ..
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2021 after market close on Wednesday, February 23rd, 2022.
Should Cytek Biosciences, Inc. (NASDAQ:CTKB) Focus On Improving This Fundamental Metric?
La Mesa, CA, based Investment company Reilly Financial Advisors, Llc (Current Portfolio) buys Sony Group Corp, The Toronto-Dominion Bank, Carrier Global Corp, Enbridge Inc, Oshkosh Corp, sells Telefonaktiebolaget L M Ericsson, HDFC Bank, EnerSys, Cytek Biosciences Inc, Dominion Energy Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Reilly Financial Advisors, Llc..
Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ..
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Cytek Biosciences, Inc. (CTKB) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
New York, NY, based Investment company Orbimed Advisors Llc (Current Portfolio) buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, HCA Healthcare Inc, Erasca Inc, sells Prelude Therapeutics Inc, Aurinia Pharmaceuticals Inc, Ascendis Pharma A/S, Natera Inc, Anthem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Orbimed Advisors Llc..
Cytek Biosciences Reports Third Quarter 2021 Financial Results
Cytek Biosciences, Inc. (CTKB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
